Actively Recruiting
Study Comparing SakuraBead Resorbable Microspheres and Shockwave Therapy for Treating Plantar Fasciitis Pain in Adults
Led by CrannMed · Updated on 2025-11-21
45
Participants Needed
1
Research Sites
39 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the safety and effectiveness of SakuraBead17 resorbable embolization microspheres compared with extracorporeal shockwave therapy ESWT for adults experiencing pain due to plantar fasciitis. This prospective, single-center, randomized, two-arm study aims to address pain caused by plantar fasciitis by comparing these two treatment methods. Approximately 45 patients will participate and be followed for six months to assess outcomes. Participants will be randomly assigned to one of two treatment groups. One group will receive arterial embolization, where resorbable microspheres are delivered through a microcatheter to temporarily block excessive blood flow in the targeted area, while preserving normal circulation. The other group will undergo ESWT, a non-invasive treatment using acoustic pulses to address the condition. Both treatments are delivered at the study center, and the safety and effectiveness will be compared over a 3-month period, with follow-ups extending to six months. Throughout the study, participants will undergo assessments to monitor safety and treatment effects, including measuring the primary effectiveness and safety endpoints at three months. Patients will receive clinical evaluations related to plantar fascia thickness and pain symptoms. The study includes thorough follow-up visits to track progress and adverse events. Participants involvement will last at least six months, with ongoing monitoring to evaluate how each treatment affects their plantar fasciitis symptoms and overall foot health.
CONDITIONS
Brief Title
SakuraBead Used as Resorbable Embolic for Plantar Fascia Embolization
Research Team
C
Chief Operations Officer
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here